Sign In
Buy TGTX
$53.94
-0.460 (-0.85%)
At Close: Jun 23, 2026
TG Therapeutics to Participate in the Jefferies Virtual London Healthcare Conference
07:00am, Friday, 13'th Nov 2020
Fireside chat scheduled for Tuesday, November 17, 2020 at 2:20 PM ET/ 7:20 PM GMT Fireside chat scheduled for Tuesday, November 17, 2020 at 2:20 PM ET/ 7:20 PM GMT
TG Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results
04:15pm, Monday, 09'th Nov 2020
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the third quarter ended September 30, 2020 and recent company developments.
TG Therapeutics Highlights Data Selected for Presentation at the 62nd American Society of Hematology (ASH) Annual Meeting
11:45am, Wednesday, 04'th Nov 2020
UNITY-CLL: U2 significantly improved progression-free survival over obinutuzimab plus chlorambucil (HR= 0 .54, p
